Scribe Therapeutics
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.
2
Funding Rounds
$120.0m
Money raised
Overview
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Be* L. Oa*** |
|
- | linkedin twitter instagram instagram |
| Je* Do**** |
|
- | linkedin twitter facebook instagram |
| Br*** T. St**** |
|
- | linkedin twitter instagram instagram |
| Da*** F. Sa**** |
|
- | linkedin linkedin twitter facebook instagram |
Industries
Scribe Therapeutics is active in the following industries: